Open AccessPhenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics
Author(s) -
Michael Gerckens,
Kenji Schorpp,
Francesco Pelizza,
Melanie Wögrath,
Kora Reichau,
Haiying Ma,
Armando-Marco Dworsky,
Arunima Sengupta,
Mircea Gabriel Stoleriu,
Katharina Heinzelmann,
Juliane Merl-Pham,
Martin Irmler,
Hani N. Alsafadi,
Eduard Trenkenschuh,
Lenka Sarnová,
Markéta Jiroušková,
Wolfgang Frieß,
Stefanie M. Hauck,
Johannes Beckers,
Nikolaus Kneidinger,
Jürgen Behr,
Anne Hilgendorff,
Kamyar Hadian,
Michael Lindner,
Mélanie Königshoff,
Oliver Eickelberg,
Martin Gregor,
Oliver Plettenburg,
Ali Önder Yildirim,
Gerald Burgstaller
Publication year - 2021
Publication title -
science advances
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.928
H-Index - 146
ISSN - 2375-2548
DOI - 10.1126/sciadv.abb3673
Subject(s) - phenotype , drug , phenotypic screening , computational biology , medicine , biology , pharmacology , bioinformatics , genetics , gene
Innovative high-content screening platform identifiedN -(2-butoxyphenyl)-3-(phenyl)acrylamides as novel antifibrotics.